TaqMan RT-PCR assay coupled with capillary electrophoresis for quantification and identification of bcr-abl transcript type

Modern Pathology

Volumn 17, Issue 1, 2004, Pages 96-103

  Luthra, Rajyalakshmi ^a   Sanchez Vega, Beatriz ^a   Medeiros, L Jeffrey ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

abl; bcr abl fusion transcripts; Capillary electrophoresis; Chronic myelogenous leukemia; GeneScan; Multiplex real time TaqMan PCR

Indexed keywords

BCR ABL PROTEIN; CHIMERIC PROTEIN; PROTEIN P190; PROTEIN P230; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW BIOPSY; CAPILLARY ELECTROPHORESIS; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLONE; EXON; FUSION GENE; GENE LOCUS; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; INTRON; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MARROW; BONE MARROW EXAMINATION; DNA PRIMERS; ELECTROPHORESIS, CAPILLARY; FLUORESCENT DYES; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAQ POLYMERASE; TRANSCRIPTION, GENETIC;

EID: 2442702517     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/sj.modpathol.3800026     Document Type: Article

References (34)

1. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960;132:1497.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-293.
3. de Klein A, Van Kessel AG, Grosveld D, et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 1982;300:765-767.
4. Groffen J, Stephenson JR, Heisterkamp N, et al. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984;36:93-99.
5. Kantarjian HM, Deisseroth A, Kuzrock R, et al. Chronic myelogenous leukemia: a concise update. Blood 1993;82:691-703.
6. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996;88:2375-2384.
7. Shtivelman E, Lifshitz B, Gale RP, et al. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985;315:550-554.
8. Ben-Neriah Y, Daley GQ, Mes-Masson AM, et al. The chronic myelogenous leukemia-specific p210 protein is the product of the bcrabl hybrid gene. Science 1986;233:212-214.
9. Hermans A, Heisterkamp N, von Linden M, et al. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 1987;51:33-40.
10. Saglio G, Guerrasio A, Rosso C, et al. New type of BCR/ABL junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1990;76:1819-1824.
11. McLaughlin J, Chianese E, Witte ON. Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol 1989;9:1866-1874.
12. Lugo TG, Pendergast AM, Muller AJ, et al. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990;247:1079-1082.
13. Heisterkamp N, Jenster G, Ten Hoeve J, et al. Acute leukemia in BCR/ABL transgenic mice. Nature 1990;344:251-253.
14. Vardiman JW, Imbert M, Pierre R, et al. Chronic myelogenous leukemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. International Agency for Research on Cancer. IARC Press: Lyon, France, 2001, pp 20-26.
15. Pane F, Frigeri F, Sindona M, et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996;88:2410-2414.
16. Mensink E, van de Locht A, Schattenberg A, et al. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol 1998;102:768-774.
17. Eder M, Battmer K, Kafert S, et al. Monitoring of BCR-ABL expression using real-time RT PCR in CML after bone marrow or peripheral blood stem cell transplantation. Leukemia 1999;13:1383-1389.
18. Branford S, Hughes TP, Rudzki Z. Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics. Br J Haematol 1999;107:587-599.
19. Emig M, Saussele S, Wittor H, et al. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real-time quantitative RT-PCR. Leukemia 1999;13:1825-1832.
20. Kreuzer KA, Lass U, Bohn A, et al. Light Cycler technology for the quantitation of BCR/ABL fusion transcripts. Cancer Res 1999;59:3171-3174.
21. Barbany G, Hagberg A, Olsson-Stromberg U, et al. Manifold-assisted reverse transcription-PCR with real-time detection for measurement of the BCR-ABL fusion transcript in chronic myeloid leukemia patients. Clin Chem 2000;46:913-920.
22. Elmaagacli AH, Beelen DW, Opalka B, et al. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage. Ann Hematol 2000;79:424-431.
23. Stentoft J, Pallisgaard N, Kjeldsen E, et al. Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol 2001;67:302-308.
24. Scheuring UJ, Pfeifer H, Wassmann B, et al. Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/BCR-ABL- positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571). Blood 2003;101:85-90.
25. Sanchez-Vega B, Vega F, Hai S, et al. Real-time t(14;18)(q32;q21) PCR assay combined with high resolution capillary electrophoresis: a novel and rapid approach that allows accurate quantitation and size determination of bcl-2/JH fusion sequences. Mod Pathol 2002;15:448-453.
26. Cross NC, Feng L, Chase A, et al. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993;82:1929-1936.
27. Guo JQ, Lin H, Kantarjian H, et al. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Leukemia 2002;16:2447-2453.
28. Perego RA, Costantini M, Cornacchini G, et al. The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukemia. Eur J Cancer 2000;36:1395-1401.
29. Prejzner W. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia. Med Sci Monit 2002;8: BR191-BR197.
30. Branford S, Hughes TP, Rudzki Z. Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene. Br J Haematol 2002;117:875-877.
31. Saglio G, Pane F, Gottardi E, et al. Consistent amounts of acute leukemia-associated p190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 1996;87:1075-1080.
32. Lichty BD, Keating A, Callum J, et al. Expression of p210 and p190 BCR/ABL due to alternative splicing in chronic myelogenous leukaemia. Br J Haematol 1998;103:711-715.
33. Van Rhee F, Szydlo RM, Hermans J, et al. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997;20:553-560.
34. Radich J, Gehly G, Lee A, et al. Detection of bcr-abl transcripts in Philadelphia Chromosome-positive acute lymphoblastic leukemia after marrow transplantation. Blood 1997;89:2602-2609.